These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21310854)

  • 1. Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis.
    Van Houtven G; Johnson FR; Kilambi V; Hauber AB
    Med Decis Making; 2011; 31(3):469-80. PubMed ID: 21310854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noisy preferences in risky choice: A cautionary note.
    Bhatia S; Loomes G
    Psychol Rev; 2017 Oct; 124(5):678-687. PubMed ID: 28569526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Efficiency of Inferences From Hybrid Samples for Effective Health Surveillance Surveys: Comprehensive Review of Quantitative Methods.
    Fahimi M; Hair EC; Do EK; Kreslake JM; Yan X; Chan E; Barlas FM; Giles A; Osborn L
    JMIR Public Health Surveill; 2024 Mar; 10():e48186. PubMed ID: 38451620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Z-Weighted Function Based on Fifth-Order Nonlinear Multi-Order Weighted Method for Shock Capturing of Hyperbolic Conservation Laws.
    Bai J; Yan Z; Mao M; Ma Y; Jiang D
    Entropy (Basel); 2024 Apr; 26(4):. PubMed ID: 38667888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A UK framework for the assessment and integration of different scientific evidence streams in chemical risk assessment.
    Doerr B; Botham P; Clare G; Gott D; Gowers A; Guercio V; Gunter Kuhnle ; Loizou G; Lovell DP; Pearce N; Rushton L; Toledano M; Wallace HM; Boobis AR
    Regul Toxicol Pharmacol; 2024 Jun; 151():105652. PubMed ID: 38839030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations in Complex Survey Data Sampling, Weighting, and Analysis for Pediatric Research.
    Chen S; Anderson MP
    J Pediatr; 2024 Jun; 273():114142. PubMed ID: 38871076
    [No Abstract]   [Full Text] [Related]  

  • 7. A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis.
    Hauber AB; Arden NK; Mohamed AF; Johnson FR; Peloso PM; Watson DJ; Mavros P; Gammaitoni A; Sen SS; Taylor SD
    Osteoarthritis Cartilage; 2013 Feb; 21(2):289-97. PubMed ID: 23182815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best-Worst Scaling Survey of Inpatients' Preferences in Medical Decision-Making Participation in China.
    Sun T; Chen H; Gao Y; Xiang Y; Wang F; Ni Z; Wang X; Huang X
    Healthcare (Basel); 2023 Jan; 11(3):. PubMed ID: 36766897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions.
    Montano-Campos JF; Gonzalez JM; Rickert T; Fairchild AO; Levitan B; Reed SD
    MDM Policy Pract; 2023; 8(1):23814683221148715. PubMed ID: 36654678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment.
    Kandzari DE; Weber MA; Poulos C; Coulter J; Cohen SA; DeBruin V; Jones D; Pathak A
    Circ Cardiovasc Qual Outcomes; 2023 Jan; 16(1):e008997. PubMed ID: 36484251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies.
    Fairchild AO; Reed SD; Gonzalez JM
    Med Decis Making; 2023 Feb; 43(2):227-238. PubMed ID: 36326189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists.
    Fernández O; Lázaro-Quintela M; Crespo G; Soto de Prado D; Pinto Á; Basterretxea L; Gómez de Liaño A; Etxaniz O; Blasco S; Gabás-Rivera C; Aceituno S; Palomar V; Polanco-Sánchez C
    Front Oncol; 2021; 11():773366. PubMed ID: 35070976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study.
    Reed SD; Yang JC; Rickert T; Johnson FR; Gonzalez JM; Mentz RJ; Krucoff MW; Vemulapalli S; Adamson PB; Gebben DJ; Rincon-Gonzalez L; Saha A; Schaber D; Stein KM; Tarver ME; Bruhn-Ding D
    Circ Heart Fail; 2022 Jan; 15(1):e008797. PubMed ID: 34937393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Preferences for Outcomes Following DCIS Management Strategies: A Discrete Choice Experiment.
    Chapman BM; Yang JC; Gonzalez JM; Havrilesky L; Reed SD; Hwang ES
    JCO Oncol Pract; 2021 Nov; 17(11):e1639-e1648. PubMed ID: 33710917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community stakeholder preferences for evidence-based practice implementation strategies in behavioral health: a best-worst scaling choice experiment.
    Williams NJ; Candon M; Stewart RE; Byeon YV; Bewtra M; Buttenheim AM; Zentgraf K; Comeau C; Shoyinka S; Beidas RS
    BMC Psychiatry; 2021 Feb; 21(1):74. PubMed ID: 33541301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial Factors Are Associated With Risk Acceptance in Upper Extremity Patients.
    Fatehi A; Ring D; Reichel LM; Vagner GA
    Hand (N Y); 2022 Sep; 17(5):988-992. PubMed ID: 33356574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two discrete choice experiments on laboratory safety decisions and practices.
    Wirth O; Foreman AM; Friedel JE; Andrew ME
    J Safety Res; 2020 Dec; 75():99-110. PubMed ID: 33334498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' Preferences after Recurrent Coronary Narrowing: Discrete Choice Experiments.
    Magliano CADS; Monteiro AL; Rebelo ARO; Santos GF; Pereira CCA; Krucien N; Saraiva RM
    Arq Bras Cardiol; 2020 Oct; 115(4):613-619. PubMed ID: 33111857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General Population vs. Patient Preferences in Anticoagulant Therapy: A Discrete Choice Experiment.
    Najafzadeh M; Schneeweiss S; Choudhry NK; Avorn J; Gagne JJ
    Patient; 2019 Apr; 12(2):235-246. PubMed ID: 30242575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis.
    Gonzalez JM
    Patient; 2018 Jun; 11(3):285-300. PubMed ID: 29332301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.